TW269636B - Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation - Google Patents

Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation

Info

Publication number
TW269636B
TW269636B TW77104438A TW77104438A TW269636B TW 269636 B TW269636 B TW 269636B TW 77104438 A TW77104438 A TW 77104438A TW 77104438 A TW77104438 A TW 77104438A TW 269636 B TW269636 B TW 269636B
Authority
TW
Taiwan
Prior art keywords
solid
nicotine
once
symptoms associated
withdrawal symptoms
Prior art date
Application number
TW77104438A
Other languages
Chinese (zh)
Inventor
Yvonne Brigid Bannon
John Corish
Owen Ignatius Corrigan
Edward James Geoghegan
Joseph G Masterson
Original Assignee
Elan Transdermal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Transdermal Ltd filed Critical Elan Transdermal Ltd
Priority to TW77104438A priority Critical patent/TW269636B/en
Application granted granted Critical
Publication of TW269636B publication Critical patent/TW269636B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid,semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous medium is formed by adding a given amount of nicotine to a solution of a solidifying or gel-forming agent or mixture thereof in a suitable solvent or mixture of solvents and mixing or heating the mixture thereby obtained so as to form the solid, semi-solid or mucilaginous medium. The preparation can be used in a method of treating withdrawal symptoms associated with smoking cessation and for combating the psychological dependence that occurs through frequent smoking.
TW77104438A 1988-06-29 1988-06-29 Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation TW269636B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW77104438A TW269636B (en) 1988-06-29 1988-06-29 Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW77104438A TW269636B (en) 1988-06-29 1988-06-29 Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation

Publications (1)

Publication Number Publication Date
TW269636B true TW269636B (en) 1996-02-01

Family

ID=51396935

Family Applications (1)

Application Number Title Priority Date Filing Date
TW77104438A TW269636B (en) 1988-06-29 1988-06-29 Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation

Country Status (1)

Country Link
TW (1) TW269636B (en)

Similar Documents

Publication Publication Date Title
EP0289342A3 (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
GB8401965D0 (en) Composition
CA1233382A (en) Transdermal delivery system for administration of nitroglycerin
ES8607723A1 (en) Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon.
KR850008279A (en) Method for preparing a transdermal drug
KR950703972A (en) TRANSADERMAL ADMINISTRATION SYSTEM CONTAINING ACETYLSALICYLIIC ACID FOR ANTITHROMBOTIC THERAPY AND THE PREVENTION OF CANCER
DE58901002D1 (en) AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES.
KR910005858A (en) Fatty acid therapy
TW269636B (en) Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation
IE873348L (en) Compositions for topical application
KR880004810A (en) Peptic Ulcer Treatment
KR890007728A (en) Painkiller
Pozuels Suppression of craving and withdrawal in humans addicted to narcotics or amphetamines by administration of alpha-methyl-para-tyrosine (AMPT) and 5-butylpicolinic acid (fusaric acid) treatment of narcotic and amphetamine addiction in humans: preliminary report
KR900017599A (en) Pharmaceutical composition for tumor treatment
JPS5762221A (en) Embrocation for external use
KR870005642A (en) Mixture of Diflunisal and Tromethamine
JPS5572108A (en) Preparation for transcutaneous administration, composed mainly of nitroglycerine
JPS59172419A (en) Method and agent for mitigating post-injection pain
KR890001567A (en) Diflunisal and Tromethamine-Containing Compositions
Streller Uterine relaxation by clenbuterol and fenoterol in conscious rats
EP0307390A3 (en) Chemical compound consisting of cis-3-hydroxyproline for therapeutic treatment, and process for its preparation
JPS5699420A (en) Immune reactivator